Lunresertib — properties from Wikipedia — wikidata.cheminfo.org

LunresertibLunresertib is an investigational new drug that is being evaluated for the treatment of cancer. It is an oral small molecule inhibitor of PKMYT1, developed by Repare Therapeutics. Read from the Drugbox of the Wikipedia article Lunresertib, revision 1372717818.

Property

Value

Formula

C18H20N4O2, 324.38 g/mol

The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.

Search — compounds by structure and property

About — sources, licence, and how to cite

Status — the daily update

API documentation

Our other tools

learn.cheminfo.org

inchi.cheminfo.org

vcl.cheminfo.org

smiles.cheminfo.org

iupac-name.cheminfo.org

openbabel.cheminfo.org

www.chemcalc.org

dbe.cheminfo.org

metabo.nmrium.com

derepflow.cheminfo.org

surge.cheminfo.org

tex.cheminfo.org

lcao.cheminfo.org

regexp.cheminfo.org

pdb.cheminfo.org

elucidation.cheminfo.org

equilibrium.cheminfo.org

polycarp.cheminfo.org

3d.cheminfo.org

periodic-table.cheminfo.org

database.cheminfo.org

symmetry.cheminfo.org

osiris.cheminfo.org

atoms.cheminfo.org

moles.cheminfo.org

inorganic.cheminfo.org

powerpoint.cheminfo.org